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The population of influenza virus consists of a huge variety of variants, called quasispecies, due to
error-prone replication. Previously, we reported that progeny virions of influenza virus become infected to
adjacent cells via cell-to-cell transmission pathway in the presence of oseltamivir. During cell-to-cell
transmission, viruses become infected to adjacent cells at high multiplicity since progeny virions are
enriched on plasma membrane between infected cells and their adjacent cells. Co-infection with
viral variants may rescue recessive mutations with each other. Thus, it is assumed that the
cell-to-cell transmission causes expansion of virus quasispecies. Here, we have demonstrated that
temperature-sensitive mutations remain in progeny viruses even at non-permissive temperature by
co-infection in the presence of oseltamivir. This is possibly due to a multiplex infection through the
cell-to-cell transmission by the addition of oseltamivir. Further, by the addition of oseltamivir, the number
of missense mutation introduced by error-prone replication in segment 8 encoding NS1 was increased in a
passage-dependent manner. The number of missense mutation in segment 5 encoding NP was not changed
significantly, whereas silent mutation was increased. Taken together, we propose that oseltamivir expands
influenza virus quasispecies via cell-to-cell transmission, and may facilitate the viral evolution and
adaptation.
R
NA viruses exist as genetically diverse populations, termed quasispecies, due to error-prone replication by
viral RNA-dependent RNA polymerases1–3. Although the high mutation rate carries a substantial risk of
production of defective progeny viruses, the expansion of virus quasispecies is a great opportunity for
viruses to evolve and escape from antiviral drugs4–8, neutralizing antibody9, and cytotoxic T-cell10,11. It is also
reported that virus quasispecies are associated with pathogenesis such as central nervous system infection of
poliovirus12,13. Mathematical models predicted that virus quasispecies are not just collection of different kind of
mutants, but a group of interactive variants, which contribute to the characteristics of the population together14.
Influenza virus is one of the most serious zoonotic pathogens causing seasonal epidemics and periodic pan-
demics among human beings around the world. The genome of influenza virus consists of eight-segmented and
single-stranded RNAs. The segmented structure of the virus genome allows genetic reassortment whenmore than
two genetically different viruses co-infect a single cell. The viral envelope consists of a lipid bilayer derived from
cellular plasmamembranewith two viral spike proteins, hemagglutinin (HA) and neuraminidase (NA). Influenza
virus infection is initiated by the attachment of HA on virus particles to terminal sialic acid residues in glyco-
conjugates15. NA possesses the enzymatic activity that cleaves a-ketosidic linkages between terminal sialic acids
and adjacent sugar residues16. In the absence of the functional sialidase activity, progeny virions are not released
from sialic acids on the plasmamembrane and found to be aggregated on the cell surface17,18. Further, it is known
that this activity contributes to prevention of successive super-infection of infected cells19.
Viruses are released as cell-free virions from an infected cell and become infected to distant cells and tissues. In
contrast, the virus transmission mechanism from an infected cell to adjacent cells without viral diffusion into the
extracellular environment, termed cell-to-cell transmission, has been reported in several viruses20,21. In general,
influenza virus becomes infected from an infected cell to uninfected cells as cell-free virions. Previously, we
reported that cell-to-cell transmission of influenza virus also occurs in the presence of oseltamivir which is a
potent inhibitor of sialidase activity of NA22–24. Since progeny virions are enriched on the plasmamembrane of an
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infected cell in the presence of oseltamivir, it is assumed that viruses
become infected to adjacent cells at high multiplicity of infection via
cell-to-cell transmission.
Here, we showed that temperature-sensitive (ts) mutations remain
in progeny viruses even at non-permissive temperature by co-infection
in the presence of oseltamivir. This is possibly due to a multiplex
infection through the cell-to-cell transmission by the addition of osel-
tamivir. Further, Next-Generation sequencing analyses revealed that
spontaneous mutations introduced by error-prone replication were
accumulated in the virus population by oseltamivir treatment. In con-
clusion, we propose that oseltamivir expands the virus quasispecies via
cell-to-cell transmission, and cell-to-cell transmission may contribute
to the evolution of influenza virus.
Results
Survival of defective variants by oseltamivir treatment. Virus
quasispecies are diversified by the error-prone virus genome
replication. Defective mutations are generated, but defective
viruses can survive in the virus quasispecies population through
incidental infection of wild-type virus or viruses containing
different type of mutation(s) as helper virus. Thus, it is suggested
that high multiplicity of infection is important for the expansion of
virus quasispecies. Recently, we found that progeny influenza virions
become infected to the adjacent cells via cell-to-cell transmission in
the presence of oseltamivir possibly with high multiplicity of
infection23. Thus, we hypothesized that oseltamivir maintains
defective variants in virus quasispecies population by co-infection.
To examine the hypothesis, we carried out co-infection experi-
ments using temperature-sensitive (ts) mutant viruses, ts1 and
ts53. The viral transcription of ts1 is defective at non-permissive
temperature due to a mutational change in PB2 polymerase subunit
at the amino acid position of 417 from Asp to Asn25,26. A point
mutation causing the change from Leu to Pro at the amino acid
position of 226 in ts53 PA polymerase subunit results in the defective
virus genome replication at non-permissive temperature27–29. Since
these point mutations are located in different virus genome seg-
ments, wild-type virus can be produced by reassortment between
ts1 and ts53 during co-infection. To perform co-infection experi-
ments using ts1 and ts53 efficiently, 0.1% confluent Madin-Darby
canine kidney (MDCK) cells were co-infected with ts1 and ts53 at
each multiplicity of infection (MOI) of 5 (Fig. 1a). In order to facil-
itate the infection of progeny viruses from co-infected cells to adja-
cent uninfected cells, fresh MDCK cells were overlaid onto co-
infected cells confluently after virus adsorption, followed by incuba-
tion at either permissive (34uC) or non-permissive temperature
(39.5uC) in the absence or presence of 50 mg/ml of oseltamivir.
Oseltamivir at the concentration of 50 mg/ml completely blocks the
release of progeny influenza viruses23. The culture medium including
progeny virions was collected at 60 hours post infection (hpi). The
viral titers of wild-type and ts mutant viruses were determined by
plaque assays at permissive and non-permissive temperatures
(Fig. 1a). It is reported that there are several mutations in NA con-
ferring resistance to oseltamivir30, but both of ts mutant viruses did
not have such mutations (Supplementary Fig. 1). The virus titer
determined by plaque assays at 34uC indicates those including ts
mutant viruses and wild-type virus, while the virus titer determined
at 39.5uC indicates that for wild-type virus alone. Therefore, the ratio
of virus titers between 34uC and 39.5uCmeans a population rate of ts
mutant viruses. During infectionwith single tsmutant, cells that were
infected with ts mutant and incubated at 34uC and 39.5uC did not
produce any wild-type virus that could grow at 39.5uC in plaque
assay (Table 1). Co-infection with ts1 and ts53 at permissive temper-
ature without oseltamivir produced 1.2 3 105 plaque forming unit
(PFU)/ml of wild-type virus possibly due to segment reassortment.
The virus titer determined at 34uC was 1.3 3 106 PFU/ml including
both tsmutant viruses and wild-type virus. Thus, the population rate
Figure 1 | Survival of temperature sensitive mutants in the presence of
oseltamivir. (a) Experimental scheme. MDCK cells were co-infected with ts1
and ts53, and then cultured at 34uC or 39.5uC in the absence or presence of
50 mg/ml of oseltamivir. Viruses grown in the presence of oseltamivir were
harvested from the cell surface by treatment with bacterial NA.
(b) Phenotyping by plaque assay. The culture supernatant was collected at
60 hpi, and then its virus titer was determined by plaque assays under both
34uC and 39.5uC. Population of tsmutant was calculated by the virus titer (T)
represented in Table 1 using following formula, {1 2 T (39.5uC)/T (34uC)
c*100. The population of ts mutant treated with oseltamivir (lane 4) was
compared with that of untreated one (lane 2) (P, 0.05). Error bars indicate
s.d. from 3 independent experiments. (c) Genotyping by Stu I digestion. Total
RNA was extracted at 40 hpi, and RT-PCR was performed using primer set
for segment 3. Subsequently, the amplified DNA products were digested with
Stu I and separated on 8% native-PAGE. Large and small fragments derived
from ts53 and ts1, the latter of which has the same genome sequence of
segment 3 as that of wild-type virus, were 220 and 199 base pairs, respectively.
P and N indicate permissive temperature (34uC) and non-permissive
temperature (39.5uC), respectively. The image of full length gel is represented
in Supplementary Figure 2.
www.nature.com/scientificreports
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of ts virus was calculated to be 91% (Table 1 and Fig. 1b). At non-
permissive temperature, co-infection with ts1 and ts53 without osel-
tamivir produced 1.6 3 105 PFU/ml of wild-type virus. The virus
titer determined at 34uC was 1.5 3 105 PFU/ml including tsmutant
viruses and wild-type virus, suggesting that the production of ts
mutant viruses hardly occurs in the absence of oseltamivir. On the
other hand, co-infection with ts1 and ts53 in the presence of oselta-
mivir at non-permissive temperature produced 6.93 103 PFU/ml of
wild-type virus, while the virus titer determined at 34uC including ts
mutant viruses and wild-type virus was 4.33 104 PFU/ml. Thus, it is
calculated that the population rate of ts mutant was 83% by co-
infection with ts1 and ts53 with oseltamivir treatment even cultured
at non-permissive temperature.
To further confirm this, total RNAwas purified from infected cells
at 40 hpi, and cDNA fragments amplified from segment 3 viral RNA
were digested by Stu I as reported previously23. ts53 virus has a
substitution mutation from U to C at the nucleotide position of
701 in segment 3 encoding PA, while the sequence of segment 3 of
ts1 virus is the same as that of wild-type virus. The digested DNA
fragments containing 220 and 199 base pairs were derived from ts53
and wild-type viruses, respectively. As expected, the virus genome
derived from ts53 was clearly found even at non-permissive temper-
ature in the presence of oseltamivir (Fig. 1c), suggesting that defective
mutations are maintained in the virus population produced in the
presence of oseltamivir.
Influenza virus particles are enriched on the cell surface by inhib-
iting the virus release from the infected cells with oseltamivir17,18.
These accumulated progeny virions may become infected to adjacent
cells via cell-to-cell transmission23. To support this, we carried out
transmission electron microscopic analyses with or without 50 mg/ml
oseltamivir. As reported previously31, large clusters of progeny virions
were attached to the apical plasma membrane by oseltamivir treat-
ment (Fig. 2a). Further, we found that, in the presence of oseltamivir,
a significant amount of the progeny virions accumulated in intercel-
lular space (Fig. 2b). Thus, it is possible that accumulated progeny
virions present in intercellular space become infected to adjacent cells
via cell-to-cell transmission in the presence of oseltamivir. Taken
these results together, progeny virions containing defective virus gen-
omes could be rescued by co-infection with helper viruses at the high
multiplicity of infection via cell-to-cell transmission.
Diversity of virus quasispecies in the presence of oseltamivir. The
fidelity of the influenza viral RNA-dependent RNA polymerase is
quite low, and therefore generates virus quasispecies32–34. In the
presence of oseltamivir, ts mutant viruses were maintained in the
virus quasispecies population via cell-to-cell transmission (Fig. 1).
Based on this, we hypothesized that spontaneous mutations
introduced by the error-prone replication are accumulated in virus
quasispecies population generated via cell-to-cell transmission in the
presence of oseltamivir. To address this, serial virus passages were
carried out in the presence or absence of oseltamivir, and mutations
were detected by Next-Generation sequencing (NGS). We generated
a recombinant WSN/33 virus by a plasmid-driven reverse genetics
method35 to prepare a monoclonal parent strain as passage 0 (P0)
virus.MDCKcells infectedwith P0 virus were cultured in the absence
or presence of 50 mg/ml of oseltamivir. When cytopathic effects
(CPE) were observed, the culture supernatant containing P1 virus
was collected and subjected to the second round infection. These
processes were serially repeated 12 times (Fig. 3a). The mutation
related with the resistance to oseltamivir was not found in P12
virus which was treated with oseltamivir (Supplementary Fig. 1).
After reverse transcription of viral RNA purified from P1, P4, P8,
and P12 viruses, cDNAs of segment 8 and segment 5 between the
nucleotide positions of 41 to 386 and 217 to 552, respectively were
amplified by PCR. To evaluate the intrinsic error rate associated with
NGS, segment 8 cDNAwas also amplified by PCR using plasmid as a
template and subjected to NGS. The error rate of NGS was 3.4 3
1025/nt. Thus, we subtracted the error rate ofNGS from themutation
rate obtained from each sample. Without oseltamivir treatment, the
number of mutation in virus quasispecies population was not
changed along with serial passages. In contrast, the mutation rates
of both segment 8 and segment 5 were clearly increased in a passage-
dependent manner by the addition of oseltamivir (Fig. 3b). These
results indicated that the spontaneous mutations introduced by the
error-prone replication are accumulated in virus quasispecies popu-
lation in the presence of oseltamivir. Nucleotide substitution results
in missense, silent, or nonsense mutation. Without oseltamivir
treatment, the number of missense, silent, and nonsense mutations
was not changed significantly. On the other hand, the number of
missense mutation of P8 and P12 virus in segment 8 was clearly
increased in the presence of oseltamivir (Fig. 3c). In the case of
segment 5, the number of silent mutation was significantly increased,
but the number of missense mutation was not increased dramatically.
Collectively, it is considered that the mutations introduced by the
error-prone replication are propagated in virus quasispecies in the
presence of oseltamivir.
Discussion
Here, we demonstrated that oseltamivir expands the influenza virus
quasispecies through the cell-to-cell transmission. By the addition of
oseltamivir, the number of missense mutation in segment 8 was
increased in a passage-dependent manner. The number of missense
mutation in segment 5 was not changed significantly, whereas silent
mutation in segment 5 was increased (Fig. 3c). It is well known that
Table 1 | Virus titer cultured under the permissive or non-permissive temperature
Infected virus Cultured at Oseltamivir
Virus titer (PFU/ml)
34uC 39.5uC
ts1 34uC 2 1.4 3 106 6 9.5 3 105 n.d.
ts1 34uC 1 2.9 3 104 6 6.5 3 103 n.d.
ts1 39.5uC 2 n.d. n.d.
ts53 34uC 2 2.2 3 106 6 8.1 3 105 n.d.
ts53 34uC 1 4.6 3 104 6 2.2 3 104 n.d.
ts53 39.5uC 2 n.d. n.d.
ts1 1 ts53 34uC 2 1.3 3 106 6 2.8 3 105 1.2 3 105 6 2.1 3 104
ts1 1 ts53 39.5uC 2 a1.5 3 105 6 4.3 3 104 a1.6 3 105 6 6.9 3 104
ts1 1 ts53 34uC 1 2.2 3 104 6 4.0 3 103 4.6 3 103 6 1.9 3 103
ts1 1 ts53 39.5uC 1 b4.3 3 104 6 2.2 3 104 b6.9 3 103 6 2.7 3 103
n.d.: not detected. 6: s.d. from 3 independent experiments.
aP . 0.5, compared with the titers between 34uC and 39.5uC.
bP , 0.05, compared with the titers between 34uC and 39. 5uC.
www.nature.com/scientificreports
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NS1 encoded by segment 8 is tolerant of amino acid changes, while NP
encoded by segment 5 is strongly restricted36. NS1 inhibits the cellular
gene expression and prevents the activation of interferon system37.
Further, NS1 selectively enhances the translation of viral mRNA and
may regulate the synthesis of viral RNA indirectly37. Although these
functions of NS1 contribute to effective virus production, NS1 is not
necessary for virus production38, suggesting that the competition
between functional and dysfunctional NS1, if any, is not completely
a serious problem. However, NP plays a key role for the virus genome
replication and necessary for infectious virus production39. It is possible
that the competition between functional and defective NP possibly as
dominant negative mutant and/or decoy could give negative effect on
the virus replication. Thus, missense mutations might not be accumu-
lated in segment 5.
In the presence of oseltamivir, progeny influenza virus virions
were found not only on apical plasma membrane but also in inter-
cellular space (Fig. 2). It is generally thought that the budding of
influenza virus as a cell-free virion occurs only from the apical sur-
face40, since HA and NA glycoproteins are intrinsically transported
to the apical plasma membrane41,42. Thus, it is assumed that the
virions accumulated on apical plasma membrane might be translo-
cated into intercellular space by trafficking of apical recycling endo-
somes to the lateral plasma membrane43. It is possible that the
intercellular space is a tight structure so as to be a barrier to fluid
between apical aqueous environment and intercellular space. Thus, it
is speculated that virions accumulated in intercellular space become
infected to adjacent cells due to decrease in concentration of oselta-
mivir in intercellular space.
Error-prone replication anticipates the existence of an error
threshold for the maintenance of genetic information. Increase of
the average error frequency above a critical threshold during virus
genome replication could cause the loss of genetic information
resulting in the extinction of virus population, called error cata-
strophe44. The existence of a threshold for the mutation rate of virus
replication has been reported. Above the 6.4 times increase in muta-
tion rate of foot-and-mouth disease virus leads to viral extinction45.
Four times increase in polio virus strongly decreases viral infectiv-
ity46. We demonstrated that the number of mutation in quasispecies
of influenza virus population in the presence of oseltamivir increased
gradually and reached around twice at P12 virus compared with that
at P1. Taken these previous reports and our study together, it is likely
that the cell-to-cell transmission in the presence of oseltamivir pro-
vides influenza virus with advantage in evolution such as a chance to
generate anti-oseltamivir viruses.
It has been reported that the cell-to-cell transmission provides
viruses with advantages. Vaccinia virus induces a blocking mech-
anism of super-infection and thereby become infected to adjacent
uninfected cells rapidly47. Viral spread via tight cell-cell contacts
allows many viruses to escape from neutralizing antibodies thus lead-
ing to immune evasion48–50. TRIM5a, that is viral restriction factor
and effectively inhibits cell-free retroviruses, are less effective to cell-
to-cell transmission51. Our findings propose a new idea that the cell-
to-cell transmission results in expansion of virus quasispecies and
may contribute to evolution and adaptation to new environments.
Methods
Cells and viruses. MDCK cells were maintained in minimal essential medium
(MEM) (Sigma) containing 10% fetal bovine serum. Influenza virus A/WSN/33 and
temperature sensitive mutants (ts1 and ts53)26,27 were used after single-plaque
isolation. MDCK cells were infected with influenza virus A/WSN/33 or tsmutants at
MOI of 0.01 PFU/cell, and incubated at 37uCand 34uC, respectively. After incubation
for 48 h, the culture fluid was harvested and centrifuged at 1,7003 g for 10 min. The
virus suspension was stored at 280uC until use.
Co-infection. To examine the transmission of influenza virus from individual co-
infected cells to adjacent cells, we carried out co-infection of ts1 and ts53. ts1 and ts53
are defective at non-permissive temperature due to a mutation in segment 1 and
segment 3, respectively. The segmented genome of influenza virus provides the
opportunity to produce reassortant viruses during co-infection in a cell. Since ts
mutations of ts1 and ts53 are located in different virus genome segments, wild-type
virus was produced by reassortment between ts1 and ts53. For efficient co-infection of
ts1 and ts53, MDCK cells at 0.1% confluency were co-infected with ts1 and ts53 at
each MOI of 5. After virus adsorption at 37uC for 1 hour, cells were washed with
serum-free MEM, and fresh MDCK cells were overlaid onto co-infected cells
confluently to examine the transmission of progeny viruses from co-infected cells to
adjacent cells. After incubation for 6 hours at either permissive (34uC) or non-
permissive temperature (39.5uC) in the absence or presence of 50 mg/ml of
oseltamivir phosphate, cells were washed with serum-free MEM. Then, maintenance
medium (MEM containing vitamins and 0.1% BSA) was added with or without
50 mg/ml of oseltamivir phosphate and cultured at either 34uC or 39.5uC. At 60 hpi,
the culture supernatant was collected, and then its virus titer was determined by
Figure 2 | Prominent localization of influenza virus in intercellular space
in the presence of oseltamivir. MDCK cells were infected with influenza
virus WSN/33 at MOI of 10 and cultured in the absence or presence of
50 mg/ml of oseltamivir phosphate. After incubation at 37uC for 16 hours,
transmission electron microscopic analyses were performed. (a) Virions
accumulated on apical plasma membrane. (b) Virions accumulated in
intercellular space. Enlarged views are shown in borders. Scale bar,
500 nm.
www.nature.com/scientificreports
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plaque assays under both 34uC and 39.5uC. Viruses grown in the presence of
oseltamivir were harvested from the cell surface by treatment with 30 mU/ml of
bacterial NA derived from Clostridiun perfringens (SIGMA).
RT-PCR. ts53 virus has a substitution mutation from U to C at the nucleotide
position of 701 in segment 3 encoding PA, while the sequence of segment 3 of ts1 virus
is the same as that of wild-type virus. To discriminate the genome of ts1 (wild-type)
and that of ts53, total RNA was reverse-transcribed by SuperScript III (Invitrogen)
with PA-895-rev (59-TTAATTTTAAGGCATCCATCAGCAGG-39), which is
complementary to positive-sense RNA of the segment 3. The cDNAwas amplified by
PCR using primers, PA-895-rev and PA-695-cut (59-TCTCCCGCCAAACTTCT-
CAGGCC-39) partially corresponding to positive-sense RNA of segment 3 between
nucleotide sequence positions 678 to 700 except for nucleotide positions 696 and 697.
Since segment 3 of ts53 has a substitution mutation from U to C at the nucleotide
position of 701, PCR products derived from wild-type could be digested by Stu I but
not that from ts53. After PCR reactions, PCR products were digested with Stu I and
separated on native-PAGE. Large and small fragments derived from ts53 and wild-
type viruses were 220 and 199 base pairs, respectively23. DNA was stained with
GelRed (BIOTIUM) and visualized by UV illumination.
Transmission electron microscope (TEM).MDCK cells were infected with virus at
MOI of 10, and cultured in the absence or presence of 50 mg/ml of oseltamivir
phosphate. After incubation at 37uC for 16 h, cells were subsequently fixed with 2.5%
of glutaraldehyde. After further fixation with 1% OsO4 for 1 h, sequential
dehydrations with ethanol in a stepwise manner were carried out followed by
propylene oxide treatment, and embedded in Poly/Bed 812 (Polysciences). Ultrathin
sections were examined with a JEM-1300 (JEOL) operated at 80 kV.
Next-generation sequencing (NGS). Amplicon generation and NGS were carried
out as previously reported52. Briefly, viral RNA was extracted using Mag/Extractor-
RNA- (TOYOBO). Total RNA was reverse-transcribed by reverse transcriptase
(TOYOBO) with oligonucleotide primers (59-AGCAAAAGCAGGGTAGATAA-39)
and (59-AGCAAAAGCAGGGTGACAAA-39), which are complementary to
nucleotide sequences between position 1 to 20 negative-sense RNAs of segment 5 and
8, respectively. The cDNA was amplified by PCR using fusion primers including
multiplex identifier tag (MID) and adaptor for 454 sequencing, (59-CGTATCG-
CCTCCCTCGCGCCATCAGTACTGAGCTACAGAACAGCTTAACAATAGA-
39) and (59-CTATGCGCCTTGCCAGCCCGCTCAGTACTGAGCTAACCC-
TGCATCAGTGAGCACA-39) corresponding to segment 5 between nucleotide
Figure 3 | Expansion of virus quasispecies by oseltamivir. (a) Experimental scheme. MDCK cells were infected with wild-type virus at MOI of 0.005 or
0.05 and cultured in the absence or presence of 50 mg/ml of oseltamivir. When CPE was observed, the culture supernatant was collected and designated
P1. Viruses grown in the presence of oseltamivir were harvested from the cell surface using bacterial NA. Supernatant P1 obtained in the absence or
presence of oseltamivir were diluted 103 times and 10 times, respectively and employed for infection in the second round of passage. After infection, cells
were cultured in the absence or presence of 50 mg/ml oseltamivir again. This procedure was repeated 12 times. (b and c) Ratio ofmutation accumulated in
virus genome. Viral RNAwas collected from supernatant P1, P4, P8, and P12, and the cDNA of segment 8 and 5 between the nucleotide positions of 41 to
386 and 217 to 552, respectively were amplified by RT-PCR. After gel purification, cDNAswere subjected toNext-Generation sequencing, and the ratio of
mutation accumulated in virus segment was calculated (b). The ratio of the mutation accumulation in P12 virus treated with oseltamivir was compared
with that of P12 virus which was not treated. *, P, 0.05. Error bars indicate s.d. from 3 independent experiments. The number of nonsense, silent, and
missense mutation in NS1 encoded by segment 8 and NP encoded by segment 5 at the amino acid positions of 13 to 113 and 65 to 162 was counted,
respectively (c).
www.nature.com/scientificreports
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sequence positions 217 to 236 and 533 to 552, respectively. To amplify segment
8 cDNA, primers, (59-CGTATCGCCTCCCTCGCGCCATCAGAGCACTGTAG-
TGTGTCAAGCTTTCAGGTAG-39) and (59-CTATGCGCCTTGCCAGCCCG-
CTCAGAGCACTGTAGGTCCATTCTGATACAAAGAGG-39) corresponding to
segment 8 between nucleotide sequence positions 41 to 60 and 366 to 386, respectively
were used. PCR products were purified by agarose gel using Fast Gene Gel Extraction
Kit (NIPPON Genetics). Amplicons were subjected to ultra-deep pyrosequencing
using GsJunior (454 Life Sciences, Roche).
Data analysis. The output from the GSJunior includes sequence results (FASTA) and
quality score for every sequence position in a read. It is known that average quality
score of a read is inversely proportional to the number of errors in that read53. To
suppress the error associated with NGS, we eliminated the reads including quality
score below 27 at one sequence position. The reads which were passed through quality
filter were aligned by ClustalW as previously reported54, and the number of mutation
in each sequence position was counted.
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